Zentalis Pharmaceuticals Inc (ZNTL)
12.06
+0.10
(+0.84%)
USD |
NASDAQ |
May 17, 16:00
12.06
0.00 (0.00%)
Pre-Market: 20:00
Zentalis Pharmaceuticals Price to Book Value: 1.868 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 1.868 |
| May 16, 2024 | 1.851 |
| May 15, 2024 | 1.854 |
| May 14, 2024 | 1.806 |
| May 13, 2024 | 1.819 |
| May 10, 2024 | 1.941 |
| May 09, 2024 | 1.938 |
| May 08, 2024 | 1.924 |
| May 07, 2024 | 1.906 |
| May 06, 2024 | 1.814 |
| May 03, 2024 | 1.813 |
| May 02, 2024 | 1.720 |
| May 01, 2024 | 1.751 |
| April 30, 2024 | 1.712 |
| April 29, 2024 | 1.768 |
| April 26, 2024 | 1.712 |
| April 25, 2024 | 1.700 |
| April 24, 2024 | 1.822 |
| April 23, 2024 | 1.946 |
| April 22, 2024 | 2.012 |
| April 19, 2024 | 2.006 |
| April 18, 2024 | 1.941 |
| April 17, 2024 | 1.967 |
| April 16, 2024 | 1.994 |
| April 15, 2024 | 2.054 |
| Date | Value |
|---|---|
| April 12, 2024 | 2.076 |
| April 11, 2024 | 2.076 |
| April 10, 2024 | 2.28 |
| April 09, 2024 | 2.436 |
| April 08, 2024 | 2.263 |
| April 05, 2024 | 2.334 |
| April 04, 2024 | 2.371 |
| April 03, 2024 | 2.418 |
| April 02, 2024 | 2.234 |
| April 01, 2024 | 2.497 |
| March 31, 2024 | |
| March 28, 2024 | 2.558 |
| March 27, 2024 | 2.465 |
| March 26, 2024 | 2.286 |
| March 25, 2024 | 2.204 |
| March 22, 2024 | 2.215 |
| March 21, 2024 | 2.225 |
| March 20, 2024 | 2.223 |
| March 19, 2024 | 2.259 |
| March 18, 2024 | 2.249 |
| March 15, 2024 | 2.324 |
| March 14, 2024 | 2.289 |
| March 13, 2024 | 2.491 |
| March 12, 2024 | 2.399 |
| March 11, 2024 | 2.262 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.445
Minimum
Nov 10 2023
14.79
Maximum
Sep 15 2021
5.077
Average
4.051
Median
Price to Book Value Benchmarks
| Revolution Medicines Inc | 3.768 |
| Day One Biopharmaceuticals Inc | 4.761 |
| Perspective Therapeutics Inc | 4.333 |
| Electromed Inc | 3.333 |
| Xtant Medical Holdings Inc | 1.967 |
Price to Book Value Related Metrics
| Price | 12.06 |
| Earnings Yield | -27.59% |
| Market Cap | 857.13M |